In the realm of clinical medicine, unexplained weight loss (UWL) presents a diagnostic challenge. It can be a harbinger of various underlying conditions, including malignancies, endocrine disorders, gastrointestinal diseases, and psychiatric illnesses. This article aims to provide a comprehensive approach to evaluating UWL in a clinical setting.
Initial assessment should include a detailed history and physical examination. The history should focus on the duration and amount of weight loss, dietary intake, symptoms of systemic diseases, and psychiatric evaluation. The physical examination should target signs of chronic diseases and nutritional deficiencies.
Basic laboratory studies, including complete blood count, metabolic panel, liver function tests, thyroid function tests, and urinalysis, should be conducted. Imaging studies should be reserved for patients with alarming symptoms or specific findings in the history or physical examination.
For older adults, malignancies and social factors like isolation and depression should be considered. In younger patients, eating disorders and malabsorption syndromes are more common. For patients with HIV/AIDS, opportunistic infections and medication side effects should be evaluated.
Management should be directed towards the underlying cause, if identified. For patients in whom no specific cause is found, a symptom-directed approach should be adopted. Regular follow-up is crucial to monitor weight and assess response to management.
Unexplained weight loss can be a symptom of a myriad of underlying diseases. A thorough and systematic approach to evaluation can help identify the cause and guide management. Understanding the potential causes and tailoring the evaluation to individual patient characteristics can improve outcomes and minimize unnecessary investigations.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation